Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols

Nobuko Hijiya, Mihaela Onciu, Scott Howard, Zhe Zhang, Cheng Cheng, John T. Sandlund, Emily P. Kyzer, Fred G. Behm, Ching Hon Pui

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

BACKGROUND. Absolute neutrophil counts (ANCs) and absolute phagocyte counts (APCs) are used to guide cancer treatment. Although automated counting could replace manual counting, data showing correlations are lacking. By analyzing blood samples from children undergoing cancer treatment, the authors determined whether ANCs and APCs obtained by automated methods correlated positively with ANCs and APCs obtained manually. METHODS. The authors analyzed 3640 consecutive peripheral blood samples. Leukocyte counts determined by Beckman-Coulter Gen-S or HmX analyzers (Beckman-Coulter, Miami, FL) were used to calculate counts obtained by automated or manual methods. Automated differential counts were obtained by automated analyzers and manual differential counts were performed by medical technologists. Counts underwent linear regression analysis. The authors evaluated 5 cutoff values for ANCs and APCs commonly used in decision-making related to cancer treatment: 300/μL, 500/μL, 750/μL, 1000/μL, and 1500/μL. Manually determined ANCs and APCs served as standards to determine the sensitivity, specificity, positive and negative predictive values, and kappa coefficient for automated counting. RESULTS. R2 values were 0.81 for ANCs determined by manual and automated methods and 0.84 for APCs determined by both methods. The specificity of the automated method was > 90% for all ranges of ANCs and APCs, except one (APCs < 300/μL). There was excellent agreement (K > 0.9) between ANCs determined by manual and automated methods and APCs calculated by both methods. CONCLUSIONS. Automated methods of determining ANCs and APCs for children undergoing cancer treatment were reliable and can replace manual counting. Blood smear examination to validate ANCs and APCs determined by automated methods was needed only in selected cases.

Original languageEnglish (US)
Pages (from-to)2681-2686
Number of pages6
JournalCancer
Volume101
Issue number11
DOIs
StatePublished - Dec 1 2004

Fingerprint

Antineoplastic Protocols
Phagocytes
Neutrophils
Pediatrics
Medical Laboratory Personnel
Neoplasms
Second Primary Neoplasms
Leukocyte Count

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols. / Hijiya, Nobuko; Onciu, Mihaela; Howard, Scott; Zhang, Zhe; Cheng, Cheng; Sandlund, John T.; Kyzer, Emily P.; Behm, Fred G.; Pui, Ching Hon.

In: Cancer, Vol. 101, No. 11, 01.12.2004, p. 2681-2686.

Research output: Contribution to journalArticle

Hijiya, N, Onciu, M, Howard, S, Zhang, Z, Cheng, C, Sandlund, JT, Kyzer, EP, Behm, FG & Pui, CH 2004, 'Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols', Cancer, vol. 101, no. 11, pp. 2681-2686. https://doi.org/10.1002/cncr.20677
Hijiya, Nobuko ; Onciu, Mihaela ; Howard, Scott ; Zhang, Zhe ; Cheng, Cheng ; Sandlund, John T. ; Kyzer, Emily P. ; Behm, Fred G. ; Pui, Ching Hon. / Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols. In: Cancer. 2004 ; Vol. 101, No. 11. pp. 2681-2686.
@article{abbae01192494deab4d014c7256e9522,
title = "Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols",
abstract = "BACKGROUND. Absolute neutrophil counts (ANCs) and absolute phagocyte counts (APCs) are used to guide cancer treatment. Although automated counting could replace manual counting, data showing correlations are lacking. By analyzing blood samples from children undergoing cancer treatment, the authors determined whether ANCs and APCs obtained by automated methods correlated positively with ANCs and APCs obtained manually. METHODS. The authors analyzed 3640 consecutive peripheral blood samples. Leukocyte counts determined by Beckman-Coulter Gen-S or HmX analyzers (Beckman-Coulter, Miami, FL) were used to calculate counts obtained by automated or manual methods. Automated differential counts were obtained by automated analyzers and manual differential counts were performed by medical technologists. Counts underwent linear regression analysis. The authors evaluated 5 cutoff values for ANCs and APCs commonly used in decision-making related to cancer treatment: 300/μL, 500/μL, 750/μL, 1000/μL, and 1500/μL. Manually determined ANCs and APCs served as standards to determine the sensitivity, specificity, positive and negative predictive values, and kappa coefficient for automated counting. RESULTS. R2 values were 0.81 for ANCs determined by manual and automated methods and 0.84 for APCs determined by both methods. The specificity of the automated method was > 90{\%} for all ranges of ANCs and APCs, except one (APCs < 300/μL). There was excellent agreement (K > 0.9) between ANCs determined by manual and automated methods and APCs calculated by both methods. CONCLUSIONS. Automated methods of determining ANCs and APCs for children undergoing cancer treatment were reliable and can replace manual counting. Blood smear examination to validate ANCs and APCs determined by automated methods was needed only in selected cases.",
author = "Nobuko Hijiya and Mihaela Onciu and Scott Howard and Zhe Zhang and Cheng Cheng and Sandlund, {John T.} and Kyzer, {Emily P.} and Behm, {Fred G.} and Pui, {Ching Hon}",
year = "2004",
month = "12",
day = "1",
doi = "10.1002/cncr.20677",
language = "English (US)",
volume = "101",
pages = "2681--2686",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols

AU - Hijiya, Nobuko

AU - Onciu, Mihaela

AU - Howard, Scott

AU - Zhang, Zhe

AU - Cheng, Cheng

AU - Sandlund, John T.

AU - Kyzer, Emily P.

AU - Behm, Fred G.

AU - Pui, Ching Hon

PY - 2004/12/1

Y1 - 2004/12/1

N2 - BACKGROUND. Absolute neutrophil counts (ANCs) and absolute phagocyte counts (APCs) are used to guide cancer treatment. Although automated counting could replace manual counting, data showing correlations are lacking. By analyzing blood samples from children undergoing cancer treatment, the authors determined whether ANCs and APCs obtained by automated methods correlated positively with ANCs and APCs obtained manually. METHODS. The authors analyzed 3640 consecutive peripheral blood samples. Leukocyte counts determined by Beckman-Coulter Gen-S or HmX analyzers (Beckman-Coulter, Miami, FL) were used to calculate counts obtained by automated or manual methods. Automated differential counts were obtained by automated analyzers and manual differential counts were performed by medical technologists. Counts underwent linear regression analysis. The authors evaluated 5 cutoff values for ANCs and APCs commonly used in decision-making related to cancer treatment: 300/μL, 500/μL, 750/μL, 1000/μL, and 1500/μL. Manually determined ANCs and APCs served as standards to determine the sensitivity, specificity, positive and negative predictive values, and kappa coefficient for automated counting. RESULTS. R2 values were 0.81 for ANCs determined by manual and automated methods and 0.84 for APCs determined by both methods. The specificity of the automated method was > 90% for all ranges of ANCs and APCs, except one (APCs < 300/μL). There was excellent agreement (K > 0.9) between ANCs determined by manual and automated methods and APCs calculated by both methods. CONCLUSIONS. Automated methods of determining ANCs and APCs for children undergoing cancer treatment were reliable and can replace manual counting. Blood smear examination to validate ANCs and APCs determined by automated methods was needed only in selected cases.

AB - BACKGROUND. Absolute neutrophil counts (ANCs) and absolute phagocyte counts (APCs) are used to guide cancer treatment. Although automated counting could replace manual counting, data showing correlations are lacking. By analyzing blood samples from children undergoing cancer treatment, the authors determined whether ANCs and APCs obtained by automated methods correlated positively with ANCs and APCs obtained manually. METHODS. The authors analyzed 3640 consecutive peripheral blood samples. Leukocyte counts determined by Beckman-Coulter Gen-S or HmX analyzers (Beckman-Coulter, Miami, FL) were used to calculate counts obtained by automated or manual methods. Automated differential counts were obtained by automated analyzers and manual differential counts were performed by medical technologists. Counts underwent linear regression analysis. The authors evaluated 5 cutoff values for ANCs and APCs commonly used in decision-making related to cancer treatment: 300/μL, 500/μL, 750/μL, 1000/μL, and 1500/μL. Manually determined ANCs and APCs served as standards to determine the sensitivity, specificity, positive and negative predictive values, and kappa coefficient for automated counting. RESULTS. R2 values were 0.81 for ANCs determined by manual and automated methods and 0.84 for APCs determined by both methods. The specificity of the automated method was > 90% for all ranges of ANCs and APCs, except one (APCs < 300/μL). There was excellent agreement (K > 0.9) between ANCs determined by manual and automated methods and APCs calculated by both methods. CONCLUSIONS. Automated methods of determining ANCs and APCs for children undergoing cancer treatment were reliable and can replace manual counting. Blood smear examination to validate ANCs and APCs determined by automated methods was needed only in selected cases.

UR - http://www.scopus.com/inward/record.url?scp=8844277548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8844277548&partnerID=8YFLogxK

U2 - 10.1002/cncr.20677

DO - 10.1002/cncr.20677

M3 - Article

VL - 101

SP - 2681

EP - 2686

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 11

ER -